Embion Technologies, a Swiss startup specializing in the development of functional nutrients for human and animal health, has announced a collaboration with Japanese brewing giant, the Asahi Group, in relation to extracting potent molecules from industrial...
Embion, a novel bioactives developer, has been awarded a grant of CHF250k (US$276k) from a Swiss public purpose fund, Foundation ALCEA, which it says will help it kick-off a Series A financing round in November.
A hydrolyzed brewers’ spent grain ingredient with prebiotic properties is the first commercial product to come out of Embion Technologies’ rapid prototyping platform, and 80 more products with microbiome modulation potential are waiting in the wings.
